What Medicines Make the Pill Less Effective?

A previous article on this blog addressed whether antibiotics reduce pill effectiveness. Most commonly prescribed antibiotics do not require extra contraception solely because of a drug interaction. Important exceptions include certain rifamycins, such as rifampin, rifabutin, and rifapentine, which need an exact-product check rather than a blanket rule about all antibiotics.

But that leaves an important question: what other medicines may interact with the pill? Some speed up hormone breakdown, some affect absorption, and some are themselves affected by hormonal contraception. A herbal supplement can matter just as much as a prescription drug. Understanding those different routes helps explain why a pharmacist checks the whole medication list.

Understanding which drugs are associated with pill interactions, and the mechanism behind them, is practically useful background information. If any of the medications below apply to your situation, the right step is a conversation with your prescriber or pharmacist, not a self-directed change to your contraception.

The Mechanism: Why Some Drugs May Affect the Pill

Contraceptive hormones are processed through several pathways. CYP3A4, part of the cytochrome P450 family of enzymes, is important for many interactions, but it is not the only pathway involved. Not every pill contains ethinylestradiol, and an explanation about one formulation should not be treated as a complete account of every oral contraceptive.

After absorption, hormones are metabolized and cleared from the body. A medicine that changes those processes can change hormone exposure. That is different from simply taking two tablets at the same time, and moving one tablet to another hour may not avoid an enzyme-inducing interaction. Ask about the mechanism rather than assuming spacing the doses solves it.

Drugs that increase the activity of hormone-metabolizing enzymes are called enzyme inducers. The resulting reduction in hormone exposure depends on the medicine and formulation. Other interactions work differently, so "not an enzyme inducer" is not a complete safety check. Our antibiotics article explains why the rifamycin concern should not be applied to every common antibiotic.

Drugs That May Affect the Pill's Effectiveness

The following examples draw on clinical guidance, studies, and official labels linked beside the relevant claims. US and UK instructions are identified where they differ. An interaction list cannot assess your exact combination, doses, medical history, or pregnancy risk, so use it to prepare questions rather than change treatment on your own.

Antibiotics: important rifamycin exceptions

Rifampin (rifampicin) and rifabutin are important antibiotic interactions. Rifapentine also carries a contraceptive warning: the US Priftin label advises an alternative nonhormonal method or an added barrier method during treatment. Read the Priftin label. The practical antibiotics guide explains the broader distinction. Ask a pharmacist for instructions covering the exact antibiotic, pill, and time after treatment ends.

Antiepileptic drugs

Several seizure medicines interact with hormonal contraception, and long-term treatment makes planning especially important. The objective is to maintain seizure control and suitable contraception together. Medicines within the same broad treatment category can behave differently, so a change should be coordinated with the specialist who manages the underlying condition.

Examples identified in CDC combined hormonal contraception guidance include:

• Carbamazepine (Tegretol), used for epilepsy, bipolar disorder, and trigeminal neuralgia. Strong CYP3A4 inducer with well-documented interactions.
• Phenytoin (Epanutin, Dilantin), an older antiepileptic with strong enzyme-inducing properties, still in use.
• Phenobarbital and primidone, primidone is metabolised to phenobarbital in the body, so both carry the same interaction concern.
• Oxcarbazepine (Trileptal), a structural relative of carbamazepine that also induces CYP3A4, though somewhat less potently.
• Topiramate (Topamax): interaction considerations can depend on the dose, but a lower dose is not permission to skip a contraception review. UK safety measures also require a Pregnancy Prevention Programme for people who can become pregnant, because pregnancy risks are a separate issue from hormone levels. Read the MHRA safety measures.

St John's Wort

St John's Wort (Hypericum perforatum) is a herbal supplement widely available without prescription and used for mild to moderate low mood. It is also a clinically significant CYP3A4 inducer, and its potential interaction with the pill is documented clearly enough that the UK Medicines and Healthcare products Regulatory Agency (MHRA) and the NHS both explicitly advise against combining it with hormonal contraceptives.

This interaction matters partly because St John's Wort is often not thought of as a medication. People may purchase it without prescription, not mention it to doctors or pharmacists, and not list it when asked about current medications. If you are using St John's Wort for any reason alongside hormonal contraception, this is something to discuss with your prescriber or pharmacist.

Modafinil

Modafinil is a wakefulness-promoting medicine that can reduce the effectiveness of steroidal contraceptives. Calling the interaction "mild" can obscure the practical precaution. UK safety advice calls for effective contraception during treatment and for two months after stopping, with a method appropriate to the interaction. Instructions can differ by country and product, so ask your prescriber for the plan that applies to you. Read the MHRA advice.

Griseofulvin

Griseofulvin is an antifungal medicine. US product labeling warns that it may increase estrogen metabolism and reduce oral contraceptive effectiveness. The appropriate precautions should be checked against the prescribed product, including instructions after treatment ends. Do not apply the warning to every antifungal or assume that every antifungal shares one mechanism. Read the griseofulvin label.

GLP-1 medicines (Mounjaro, Ozempic, Wegovy)

Tirzepatide, sold as Mounjaro, works differently from enzyme inducers: delayed stomach emptying may affect oral contraceptive absorption. The US label advises switching to a non-oral method or adding a barrier method for four weeks after starting and for four weeks after each dose increase. Read the Mounjaro label. Other GLP-1 medicines should not automatically inherit this exact rule. Vomiting or diarrhea requires a separate pill-specific check. See the guide to GLP-1 medicines and contraception.

What These Interactions Mean in Practice

An interaction does not give a simple countdown to loss of protection, and a percentage drop in hormone exposure does not translate directly into a personal pregnancy probability. The medicine, dose, contraceptive, and duration of treatment all matter. Do not wait for spotting or another symptom before asking for advice: symptoms are not an interaction test.

For long-term seizure treatment, a clinician may consider an unaffected contraceptive method or, where appropriate, a treatment alternative. Changing seizure medication is not automatically the simplest or safest solution. It requires specialist assessment of seizure control and the risks of switching. A coordinated plan should explain what to use during any transition, rather than leaving contraceptive cover uncertain.

Short courses also need a plan. A prescription for rifampin should trigger a contraception check even if you will take it only temporarily. Ask whether an alternative method is preferable, whether a barrier method is part of the plan, and exactly when precautions can end. The interaction can persist after the final dose, so do not use the antibiotic finish date as an assumed finish date for precautions.

If you take St John's wort, tell your pharmacist and the professional managing your mood symptoms. The MHRA advises against combining it with hormonal contraception for pregnancy prevention. Ask how to manage the supplement and contraception safely, including any period after stopping it, and discuss other support for the reason you were taking it. Read the MHRA advice.

Reference Table: Drugs and Their Interaction Status

The table below summarises published guidance. It is a general reference only and does not replace individual clinical assessment. Always confirm with a prescriber or pharmacist for your specific situation.

Correction, 28 September 2026: Expanded the rifamycin examples, clarified topiramate and valproate pregnancy precautions, and removed wording suggesting the app determines backup-contraception days.